Economic Compensation to Increase Demand for Voluntary Medical Male Circumcision

NCT01857700 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1504

Last updated 2014-04-25

No results posted yet for this study

Summary

Research questions: What effect does provision of food vouchers have on uptake of voluntary medical male circumcision? What is the amount of food voucher that should be given?

Hypothesis: The percentage of men who are compensated for costs of travel to and lost wages due to VMMC and who undergo VMMC will be higher than the percentage of men who are compensated for lost wages or travel and undergo VMMC, and both of these percentages will be higher than the percentage of men who are not compensated for travel or lost wage costs but undergo VMMC.

Conditions

  • Voluntary Medical Male Circumcision
  • Circumcision Adult

Interventions

OTHER

Compensation for transport cost

OTHER

Compensation for lost wages

OTHER

Compensation for transport cost and lost wages

OTHER

Standard of Care

Consistent with standard of care, participants in this group will be offered a refreshment during their office visit.

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER
  • Impact Research & Development Organization

    collaborator OTHER
  • FHI 360

    collaborator OTHER
  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Harsha Thirumurthy, PhD · UNC-Chapel Hill, CPC and SPH-HPM

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
25 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01857700 on ClinicalTrials.gov